Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem Cell Transplant for DOCK8 Deficiency
NCT01176006Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Oct 2010
- Primary completion
- Oct 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of hematopoietic stem cells in DOCK8 deficiency (DOCK8D), sponsored by National Cancer Institute. Started Oct 2010; status: active, not recruiting.
02
Drugs
hematopoietic stem cells
03
Conditions
DOCK8 deficiency (DOCK8D)
Beyond the preview
Go deeper on NCT01176006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176006.